18 November 2016Americas

Federal Circuit affirms Roxane’s patent not infringed

The US Court of Appeals for the Federal Circuit has affirmed a district court’s ruling holding that Camber Pharmaceuticals and Invagen Pharmaceuticals do not infringe Roxane Laboratories’ patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk